Zholobenko A: Difference between revisions
From Bioblast
Nirschl Lisa (talk | contribs) No edit summary |
Beno Marija (talk | contribs) Β |
||
| Line 15: | Line 15: | ||
== Participated at == | == Participated at == | ||
::::* [[IOC125]] | ::::* [[IOC125|IOC125 Prague CZ]] | ||
Latest revision as of 12:23, 14 February 2018
| Name | Zholobenko Aleksey, PhD |
|---|---|
| Institution | Department of Medical Chemistry and Biochemistry
Faculty of Medicine and Dentistry Palacky University |
| Address | HnΔvotΓnskΓ‘ 3, 779 00 |
| City | Olomouc |
| State/Province | |
| Country | Czech Republic |
| [email protected] | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Pola 2020 Invest New Drugs | 2020 | Pola M, Kolarova H, Ruzicka J, Zholobenko A, Modriansky M, Mosinger J, Bajgar R (2020) Effects of zinc porphyrin and zinc phthalocyanine derivatives in photodynamic anticancer therapy under different partial pressures of oxygen in vitro. Invest New Drugs 39:89-97. |
